Acta Med. 2021, 64: 227-231
https://doi.org/10.14712/18059694.2022.7
Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report
References
1. J Dent Res 2021; 100(2): 141–54.
< Dos Santos J, Normando AGC, et al. Oral Manifestations in Patients with COVID-19: A Living Systematic Review. https://doi.org/10.1177/0022034520957289>
2. Indian J Forens Med Toxicol 2021; 15(3): 240–4.
K, Karadwal A, Nayak P, Nayak S. Mucormycosis in Post Covid Patient - A Case Report.
3. Morbidity and Mortality Weekly Report. 2021; 70(2): 56–7.
< C, Anderson E, Forsberg K, et al. Candida auris outbreak in a COVID-19 specialty care unit – Florida, July–August 2020. https://doi.org/10.15585/mmwr.mm7002e3>
<PubMed>
4. J Maxillofac Oral Surg 2021; 20(3): 1–8.
< A, Gaikwad R, Krishna S, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids-An unholy trinity in invasive fungal infections of the maxillofacial region? A Retrospective, Multi-centric Analysis. https://doi.org/10.1007/s12663-021-01532-1>
<PubMed>
5. Infection 2021; 49(1): 15–28.
< D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. https://doi.org/10.1007/s15010-020-01509-1>
<PubMed>
6. Lancet Respir Med 2020; 8(4): 420–2.
< Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. https://doi.org/10.1016/S2213-2600(20)30076-X>
<PubMed>
7. Int J Epidemiol 2020; 49(3): 717–26.
< NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? https://doi.org/10.1093/ije/dyaa033>
<PubMed>
8. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2003; 15(10): 582–4. In Chinese.
CS, Pan SF. Analysis and causation discussion of 185 severe acute respiratory syndrome dead cases.
9. Cureus 2020; 12: e10726.
S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19.
10. IP Arch Cytol Histopathology Res 2021; 6(2): 135–9.
< SV, Jagtap SS, Nagar V, Varshney K. Invasive mucormycosis in post COVID-19 infection: Case report with review. https://doi.org/10.18231/j.achr.2021.033>
11. Int J Oral Maxillofac Pathol 2012; 3(3): 8–12.
N, Kumar G, Deshmukh R. Oral mucormycosis causing necrotizing lesion in a diabetic patient: a case report.
12. Dental clinics of North America 2013; 57(4): 561–81.
< BC, Epifanio RN. Update on oral fungal infections. https://doi.org/10.1016/j.cden.2013.07.002>
13. SN Compr Clin Med 2021 Mar 27: 1-12.
AB, Muddana K, Bakki SR. Fungal infections of oral cavity: Diagnosis, management, and association with COVID-19.
14. J Oral Maxillofac Pathol 2014; 18(2): 235–43.
< A, Nair BJ, Sivakumar T, Joseph AP. Uncommon opportunistic fungal infections of oral cavity: a review. https://doi.org/10.4103/0973-029X.140765>
<PubMed>
15. Acta Stomatologica Croatica 2019; 53(3): 274–7.
< Boras V, Jurlina M, Brailo V, Đurić Vuković K, et al. Oral mucormycosis and aspergillosis in the patient with acute leukemia. https://doi.org/10.15644/asc53/3/9>
<PubMed>
16. BMC Infect Dis 2013; 13: 59.
< E, Escobar Salazar N, Sepehrkhouy S, Meijer M, de Cock H, Haas PJ. Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: a case report. https://doi.org/10.1186/1471-2334-13-59>
<PubMed>
17. J Fungi (Basel) 2018; 4(3): 98.
< JD, Hoenigl M. Treatment of Aspergillosis. https://doi.org/10.3390/jof4030098>
<PubMed>
18. Laryngoscope 2021; 00: 1–7.
NA, El-Fattah AMA, Khafagy YK. Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity.
19. Adv Case Stud 2021; 3(1): AICS.000555.
C, Devi P, Deka B, Sharma DK. Mucormycosis and Aspergillosis have been linked to Covid- 19-related fungal infections in India.
20. Diab Metabol Synd Clin Res Rev 2020; 14: 1889–94.
R, Misra A. Infections and diabetes: risks and mitigation with reference to India.